"10.1371_journal.pone.0016788","plos one","2011-03-07T00:00:00Z","Avinash Gill; Thomas C Scanlon; Daniel C Osipovitch; Dean R Madden; Karl E Griswold","Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, United States of America; Program in Experimental and Molecular Medicine, Dartmouth College, Hanover, New Hampshire, United States of America; Department of Biochemistry, Dartmouth Medical School, Dartmouth College, Hanover, New Hampshire, United States of America; Program in Molecular and Cellular Biology, Dartmouth College, Hanover, New Hampshire, United States of America; Department of Biological Sciences, Dartmouth College, Hanover, New Hampshire, United States of America","Conceived and designed the experiments: AG TCS KEG. Performed the experiments: AG DCO KEG. Analyzed the data: AG DCO KEG. Contributed reagents/materials/analysis tools: TCS DRM. Wrote the paper: AG DRM KEG.","KEG and TCS have filed a patent application on the therapeutic applications of the engineered human lysozyme. PCT/US10/21363 entitled Therepeutic Charge Engineered Variants of Lysozyme and Methods for Using the Same to Treat Infections was filed on January 16, 2010. This patent application does not alter the authors willingness to adhere to all the PLoS ONE policies on sharing data and materials.","2011","03","Avinash Gill","AG",5,TRUE,3,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
